2D Barcode Scanner
This report aims to provide a comprehensive presentation of the global market for 2D Barcode Scan ... Read More
Global Wet Age Related Macular Degeneration (AMD) Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Wet Age-Related Macular Degeneration (Wet AMD)
1.2.3 Dry Age-Related Macular Degeneration (Dry AMD)
1.3 Market by Age
1.3.1 Global Wet Age Related Macular Degeneration (AMD) Market Growth by Age: 2018 VS 2022 VS 2029
1.3.2 Above 75 Years
1.3.3 Above 60 Years
1.3.4 Above 40 Years
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Wet Age Related Macular Degeneration (AMD) Market Perspective (2018-2029)
2.2 Wet Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Global Wet Age Related Macular Degeneration (AMD) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Wet Age Related Macular Degeneration (AMD) Historic Market Size by Region (2018-2023)
2.2.3 Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2024-2029)
2.3 Wet Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Wet Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Wet Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Wet Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Wet Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue
3.1.1 Global Top Wet Age Related Macular Degeneration (AMD) Players by Revenue (2018-2023)
3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2018-2023)
3.2 Global Wet Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Wet Age Related Macular Degeneration (AMD) Revenue
3.4 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Wet Age Related Macular Degeneration (AMD) Revenue in 2022
3.5 Wet Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.6 Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Type (2018-2023)
4.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2024-2029)
5 Wet Age Related Macular Degeneration (AMD) Breakdown Data by Age
5.1 Global Wet Age Related Macular Degeneration (AMD) Historic Market Size by Age (2018-2023)
5.2 Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2024-2029)
6 North America
6.1 North America Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
6.2 North America Wet Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
6.4 North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
7.2 Europe Wet Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
7.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
8.2 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
9.2 Latin America Wet Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
9.4 Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
10.2 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis International (Switzerland)
11.1.1 Novartis International (Switzerland) Company Detail
11.1.2 Novartis International (Switzerland) Business Overview
11.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction
11.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.1.5 Novartis International (Switzerland) Recent Development
11.2 Bayer (Germany)
11.2.1 Bayer (Germany) Company Detail
11.2.2 Bayer (Germany) Business Overview
11.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Introduction
11.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.2.5 Bayer (Germany) Recent Development
11.3 Acucela (US)
11.3.1 Acucela (US) Company Detail
11.3.2 Acucela (US) Business Overview
11.3.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.3.5 Acucela (US) Recent Development
11.4 Neurotech Pharmaceuticals (US)
11.4.1 Neurotech Pharmaceuticals (US) Company Detail
11.4.2 Neurotech Pharmaceuticals (US) Business Overview
11.4.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.4.5 Neurotech Pharmaceuticals (US) Recent Development
11.5 Ophthotech (US)
11.5.1 Ophthotech (US) Company Detail
11.5.2 Ophthotech (US) Business Overview
11.5.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.5.5 Ophthotech (US) Recent Development
11.6 GlaxoSmithKline (US)
11.6.1 GlaxoSmithKline (US) Company Detail
11.6.2 GlaxoSmithKline (US) Business Overview
11.6.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.6.5 GlaxoSmithKline (US) Recent Development
11.7 Alimera Sciences (US)
11.7.1 Alimera Sciences (US) Company Detail
11.7.2 Alimera Sciences (US) Business Overview
11.7.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.7.5 Alimera Sciences (US) Recent Development
11.8 StemCell (Canada)
11.8.1 StemCell (Canada) Company Detail
11.8.2 StemCell (Canada) Business Overview
11.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Introduction
11.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.8.5 StemCell (Canada) Recent Development
11.9 F. Hoffmann-La Roche (Switzerland)
11.9.1 F. Hoffmann-La Roche (Switzerland) Company Detail
11.9.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Introduction
11.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.9.5 F. Hoffmann-La Roche (Switzerland) Recent Development
11.10 Regeneron Pharmaceutical (US)
11.10.1 Regeneron Pharmaceutical (US) Company Detail
11.10.2 Regeneron Pharmaceutical (US) Business Overview
11.10.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.10.5 Regeneron Pharmaceutical (US) Recent Development
11.11 Allergan (Ireland)
11.11.1 Allergan (Ireland) Company Detail
11.11.2 Allergan (Ireland) Business Overview
11.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Introduction
11.11.4 Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.11.5 Allergan (Ireland) Recent Development
11.12 Adverum Biotechnologies (US)
11.12.1 Adverum Biotechnologies (US) Company Detail
11.12.2 Adverum Biotechnologies (US) Business Overview
11.12.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.12.4 Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.12.5 Adverum Biotechnologies (US) Recent Development
11.13 Gilead Sciences (US)
11.13.1 Gilead Sciences (US) Company Detail
11.13.2 Gilead Sciences (US) Business Overview
11.13.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Introduction
11.13.4 Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
11.13.5 Gilead Sciences (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Wet Age-Related Macular Degeneration (Wet AMD)
Table 3. Key Players of Dry Age-Related Macular Degeneration (Dry AMD)
Table 4. Global Wet Age Related Macular Degeneration (AMD) Market Size Growth by Age (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Wet Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Wet Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region (2018-2023)
Table 8. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region (2024-2029)
Table 10. Wet Age Related Macular Degeneration (AMD) Market Trends
Table 11. Wet Age Related Macular Degeneration (AMD) Market Drivers
Table 12. Wet Age Related Macular Degeneration (AMD) Market Challenges
Table 13. Wet Age Related Macular Degeneration (AMD) Market Restraints
Table 14. Global Wet Age Related Macular Degeneration (AMD) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players (2018-2023)
Table 16. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2022)
Table 17. Ranking of Global Top Wet Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Wet Age Related Macular Degeneration (AMD) Product Solution and Service
Table 21. Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2018-2023)
Table 25. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2024-2029)
Table 27. Global Wet Age Related Macular Degeneration (AMD) Market Size by Age (2018-2023) & (US$ Million)
Table 28. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Age (2018-2023)
Table 29. Global Wet Age Related Macular Degeneration (AMD) Forecasted Market Size by Age (2024-2029) & (US$ Million)
Table 30. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Age (2024-2029)
Table 31. North America Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis International (Switzerland) Company Detail
Table 47. Novartis International (Switzerland) Business Overview
Table 48. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product
Table 49. Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 50. Novartis International (Switzerland) Recent Development
Table 51. Bayer (Germany) Company Detail
Table 52. Bayer (Germany) Business Overview
Table 53. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product
Table 54. Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 55. Bayer (Germany) Recent Development
Table 56. Acucela (US) Company Detail
Table 57. Acucela (US) Business Overview
Table 58. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product
Table 59. Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 60. Acucela (US) Recent Development
Table 61. Neurotech Pharmaceuticals (US) Company Detail
Table 62. Neurotech Pharmaceuticals (US) Business Overview
Table 63. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product
Table 64. Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 65. Neurotech Pharmaceuticals (US) Recent Development
Table 66. Ophthotech (US) Company Detail
Table 67. Ophthotech (US) Business Overview
Table 68. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product
Table 69. Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 70. Ophthotech (US) Recent Development
Table 71. GlaxoSmithKline (US) Company Detail
Table 72. GlaxoSmithKline (US) Business Overview
Table 73. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product
Table 74. GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 75. GlaxoSmithKline (US) Recent Development
Table 76. Alimera Sciences (US) Company Detail
Table 77. Alimera Sciences (US) Business Overview
Table 78. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product
Table 79. Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 80. Alimera Sciences (US) Recent Development
Table 81. StemCell (Canada) Company Detail
Table 82. StemCell (Canada) Business Overview
Table 83. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product
Table 84. StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 85. StemCell (Canada) Recent Development
Table 86. F. Hoffmann-La Roche (Switzerland) Company Detail
Table 87. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 88. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product
Table 89. F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 90. F. Hoffmann-La Roche (Switzerland) Recent Development
Table 91. Regeneron Pharmaceutical (US) Company Detail
Table 92. Regeneron Pharmaceutical (US) Business Overview
Table 93. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product
Table 94. Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 95. Regeneron Pharmaceutical (US) Recent Development
Table 96. Allergan (Ireland) Company Detail
Table 97. Allergan (Ireland) Business Overview
Table 98. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product
Table 99. Allergan (Ireland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 100. Allergan (Ireland) Recent Development
Table 101. Adverum Biotechnologies (US) Company Detail
Table 102. Adverum Biotechnologies (US) Business Overview
Table 103. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product
Table 104. Adverum Biotechnologies (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 105. Adverum Biotechnologies (US) Recent Development
Table 106. Gilead Sciences (US) Company Detail
Table 107. Gilead Sciences (US) Business Overview
Table 108. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product
Table 109. Gilead Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 110. Gilead Sciences (US) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Wet Age Related Macular Degeneration (AMD) Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Wet Age Related Macular Degeneration (AMD) Market Share by Type: 2022 VS 2029
Figure 3. Wet Age-Related Macular Degeneration (Wet AMD) Features
Figure 4. Dry Age-Related Macular Degeneration (Dry AMD) Features
Figure 5. Global Wet Age Related Macular Degeneration (AMD) Market Size Comparison by Age (2023-2029) & (US$ Million)
Figure 6. Global Wet Age Related Macular Degeneration (AMD) Market Share by Age: 2022 VS 2029
Figure 7. Above 75 Years Case Studies
Figure 8. Above 60 Years Case Studies
Figure 9. Above 40 Years Case Studies
Figure 10. Wet Age Related Macular Degeneration (AMD) Report Years Considered
Figure 11. Global Wet Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Wet Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Wet Age Related Macular Degeneration (AMD) Market Share by Region: 2022 VS 2029
Figure 14. Global Wet Age Related Macular Degeneration (AMD) Market Share by Players in 2022
Figure 15. Global Top Wet Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wet Age Related Macular Degeneration (AMD) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Wet Age Related Macular Degeneration (AMD) Revenue in 2022
Figure 17. North America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2018-2029)
Figure 19. United States Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Wet Age Related Macular Degeneration (AMD) Market Share by Country (2018-2029)
Figure 23. Germany Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Market Share by Region (2018-2029)
Figure 31. China Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Wet Age Related Macular Degeneration (AMD) Market Share by Country (2018-2029)
Figure 39. Mexico Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Wet Age Related Macular Degeneration (AMD) Market Share by Country (2018-2029)
Figure 43. Turkey Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 46. Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 47. Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 48. Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 49. Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 50. GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 51. Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 52. StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 53. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 54. Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 55. Allergan (Ireland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 56. Adverum Biotechnologies (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 57. Gilead Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis International (Switzerland) Bayer (Germany) Acucela (US) Neurotech Pharmaceuticals (US) Ophthotech (US) GlaxoSmithKline (US) Alimera Sciences (US) StemCell (Canada) F. Hoffmann-La Roche (Switzerland) Regeneron Pharmaceutical (US) Allergan (Ireland) Adverum Biotechnologies (US) Gilead Sciences (US)